ArticleNature communications2019
Integrating temporal and spatial control of electronic transitions for bright multiphoton upconversion.
Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Manipulatable Cascade Pumping Single-Photon Upconversion.Nature communications · 2026Article
- Beyond the visible: metal-ion-doped inorganic UV phosphors for advanced photonics.Light, science & applications · 2026Review
- Dye-sensitized cascaded energy transfer for amplified 1525 nm luminescence in highly doped lanthanide nanoparticles.Light, science & applications · 2026Article
- Ultraviolet Light Generation through Lanthanide Upconversion.Accounts of chemical research · 2026Article
- A multiband NIR upconversion core-shell design for enhanced light harvesting of silicon solar cells.Light, science & applications · 2024Article
- Spatiotemporal control of photochromic upconversion through interfacial energy transfer.Nature communications · 2024Article
- In Vivo High-Contrast Biomedical Imaging in the Second Near-Infrared Window Using Ultrabright Rare-Earth Nanoparticles.Nano letters · 2023Article
- Artificial intelligence reinforced upconversion nanoparticle-based lateral flow assay via transfer learning.Fundamental research · 2023Article
- Significant Enhancement of the Upconversion Emission in Highly ErAngewandte Chemie (International ed. in English) · 2023Article
- Bioimaging with Upconversion Nanoparticles.Advanced photonics research · 2022Article
- Towards highly efficient NIR II response up-conversion phosphor enabled by long lifetimes of ErNature communications · 2022Article
- Excitation energy mediated cross-relaxation for tunable upconversion luminescence from a single lanthanide ion.Nature communications · 2022Article
- Fluorescent Nanoparticles for Super-Resolution Imaging.Chemical reviews · 2022Review
- Article
- Ultralarge anti-Stokes lasing through tandem upconversion.Nature communications · 2022Article
- Dye Sensitization for Ultraviolet Upconversion Enhancement.Nanomaterials (Basel, Switzerland) · 2021Article
- Mechanisms of Upconversion Luminescence of ErNanomaterials (Basel, Switzerland) · 2021Article
- Six-photon upconverted excitation energy lock-in for ultraviolet-C enhancement.Nature communications · 2021Article
- Networking State of Ytterbium Ions Probing the Origin of Luminescence Quenching and Activation in Nanocrystals.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021Article
- Experimental validation of a modeling framework for upconversion enhancement in 1D-photonic crystals.Nature communications · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The applications of lanthanide-doped upconversion nanomaterials are limited by unsatisfactory brightness currently. Herein, a general strategy is proposed for boosting the upconversion efficiency in Er
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.